{"id":"fibroblasts-and-keratinocytes","safety":{"commonSideEffects":[{"rate":null,"effect":"Infection at application site"},{"rate":null,"effect":"Immune reaction"},{"rate":null,"effect":"Graft rejection"}]},"_chembl":{"chemblId":"CHEMBL1628401","moleculeType":"Small molecule","molecularWeight":"657.81"},"_dailymed":{"setId":"2dedbdf1-ba02-476c-94b5-80ee314d9c9f","title":"GINTUIT (ALLOGENEIC CULTURED KERATINOCYTES AND FIBROBLASTS IN BOVINE COLLAGEN) CELLULAR SHEET [ORGANOGENESIS, INC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fibroblasts and keratinocytes are primary cell types involved in skin and tissue repair. When cultured and applied therapeutically, they secrete growth factors and extracellular matrix components that stimulate angiogenesis, collagen deposition, and epithelialization. This cellular approach aims to restore damaged or deficient tissue through biological regeneration rather than pharmacological mechanisms.","oneSentence":"This is a cellular therapy product consisting of cultured fibroblasts and keratinocytes that promote tissue regeneration and wound healing.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T06:03:13.819Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Wound healing and tissue regeneration"},{"name":"Burn injuries"},{"name":"Chronic wounds"}]},"trialDetails":[{"nctId":"NCT01306019","phase":"PHASE1, PHASE2","title":"Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-09-25","conditions":"X-linked Severe Combined Immunodeficiency (XSCID)","enrollment":40},{"nctId":"NCT06325709","phase":"PHASE1, PHASE2","title":"Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-04-17","conditions":"Chronic Granulomatous Disease (CGD), X-Linked Chronic Granulomatous Disease","enrollment":10},{"nctId":"NCT06851767","phase":"PHASE1, PHASE2","title":"Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-05-09","conditions":"X-linked Severe Combined Immunodeficiency, X-SCID, XSCID","enrollment":18},{"nctId":"NCT04177004","phase":"PHASE1","title":"Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2021-04-30","conditions":"Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":53},{"nctId":"NCT07222540","phase":"","title":"Expanded Access Program Evaluating SkinTE in the Treatment of Wagner 1 Diabetic Foot Ulcers","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"PolarityTE","startDate":"","conditions":"DFU, Neuropathic Diabetic Ulcer - Foot, Diabetic Foot Disease","enrollment":""},{"nctId":"NCT07143760","phase":"","title":"Topical Hyaluronic Acid Adjunctive Effects on Healing After Free Gingival Grafting in Smokers and Non-Smokers","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2018-01-01","conditions":"Recession, Gingival, Tissue Grafts","enrollment":80},{"nctId":"NCT06140303","phase":"PHASE3","title":"SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)","status":"ACTIVE_NOT_RECRUITING","sponsor":"PolarityTE","startDate":"2024-02-22","conditions":"Diabetic Foot","enrollment":100},{"nctId":"NCT05139004","phase":"PHASE1","title":"90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2022-07-19","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":7},{"nctId":"NCT06745557","phase":"PHASE3","title":"Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents","status":"RECRUITING","sponsor":"CUTISS AG","startDate":"2024-12-13","conditions":"Burns","enrollment":70},{"nctId":"NCT03334656","phase":"PHASE1, PHASE2","title":"Controlled Comparison of a Traditional Dressing Versus a Biologic Dressing Composed of Fetal Fibroblasts and Keratinocytes in Association With a Collagen Matrix on Skin Donor Sites","status":"TERMINATED","sponsor":"Nantes University Hospital","startDate":"2018-05-16","conditions":"Split Thickness Skin Graft, Wound Healing","enrollment":28},{"nctId":"NCT05372809","phase":"PHASE3","title":"Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs","status":"TERMINATED","sponsor":"PolarityTE","startDate":"2022-04-28","conditions":"Diabetic Foot","enrollment":42},{"nctId":"NCT05234658","phase":"PHASE2","title":"Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery","status":"UNKNOWN","sponsor":"Andalusian Network for Design and Translation of Advanced Therapies","startDate":"2022-01-21","conditions":"Basal Cell Carcinoma","enrollment":21},{"nctId":"NCT02554851","phase":"PHASE3","title":"Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.","status":"UNKNOWN","sponsor":"The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)","startDate":"2017-01","conditions":"Foot Ulcer, Diabetic, Epidermal Growth Factor","enrollment":304},{"nctId":"NCT04554732","phase":"EARLY_PHASE1","title":"Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2020-04-27","conditions":"Alopecia, Chemotherapy-Induced Change, Hair Loss","enrollment":28},{"nctId":"NCT04915391","phase":"","title":"Restenosis in Coronary Stents And Cutaneous HEaLing","status":"UNKNOWN","sponsor":"Fundación para la Investigación Biosanitaria del Principado de Asturias","startDate":"2017-04-25","conditions":"Coronary Restenosis, Coronary Stent Occlusion, Skin Scarring","enrollment":80},{"nctId":"NCT00376935","phase":"PHASE2","title":"Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-12","conditions":"HIV Infections","enrollment":99},{"nctId":"NCT03005054","phase":"PHASE2","title":"StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects","status":"TERMINATED","sponsor":"Stratatech, a Mallinckrodt Company","startDate":"2017-04-24","conditions":"Trauma-related Wound, Burns, Skin Wound","enrollment":3},{"nctId":"NCT03005106","phase":"PHASE3","title":"StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements","status":"COMPLETED","sponsor":"Stratatech, a Mallinckrodt Company","startDate":"2017-05-30","conditions":"Burn, Thermal","enrollment":71},{"nctId":"NCT04485962","phase":"PHASE1, PHASE2","title":"Treatment of Patients With Skin Burns Using Keratinocytes and Skin Fibroblasts","status":"COMPLETED","sponsor":"Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus","startDate":"2017-01-01","conditions":"Burns","enrollment":12},{"nctId":"NCT03547635","phase":"NA","title":"AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Integra LifeSciences Corporation","startDate":"2018-05-03","conditions":"Diabetic Foot Ulcer","enrollment":116},{"nctId":"NCT02657876","phase":"PHASE1","title":"ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Stratatech, a Mallinckrodt Company","startDate":"2018-01-31","conditions":"Diabetes, Diabetic Foot Ulcer, Non-healing Wound","enrollment":5},{"nctId":"NCT01712945","phase":"PHASE1, PHASE2","title":"Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis","status":"TERMINATED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2012-06","conditions":"Multiple Sclerosis","enrollment":40},{"nctId":"NCT03531281","phase":"PHASE1","title":"Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant","status":"WITHDRAWN","sponsor":"City of Hope Medical Center","startDate":"2018-12-30","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Hematopoietic Cell Transplantation Recipient","enrollment":""},{"nctId":"NCT00728585","phase":"PHASE2","title":"Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant","status":"WITHDRAWN","sponsor":"Children's Oncology Group","startDate":"2008-03-13","conditions":"Gastrointestinal Mucositis, Malignant Neoplasm","enrollment":""},{"nctId":"NCT00593554","phase":"PHASE2","title":"Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies","status":"TERMINATED","sponsor":"Sherif S. Farag","startDate":"2007-08-07","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplasia","enrollment":9},{"nctId":"NCT03100877","phase":"PHASE1, PHASE2","title":"Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma","status":"WITHDRAWN","sponsor":"City of Hope Medical Center","startDate":"2018-01","conditions":"Plasma Cell Leukemia in Remission, Plasma Cell Myeloma","enrollment":""},{"nctId":"NCT01134081","phase":"NA","title":"Expression of Angiogenic Biomarkers During Healing of Intra-Oral Soft Tissue Engineered Grafts","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2008-01","conditions":"Gingival Recession","enrollment":44},{"nctId":"NCT02653196","phase":"EARLY_PHASE1","title":"A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2015-09","conditions":"Neuroepithelial Tumor, Solid Tumor, Allogeneic Hematopoietic Stem Cell Transplantation","enrollment":1},{"nctId":"NCT01737762","phase":"PHASE3","title":"Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2","status":"COMPLETED","sponsor":"Healthpoint","startDate":"2012-11","conditions":"Venous Leg Ulcers","enrollment":155},{"nctId":"NCT01190865","phase":"PHASE1","title":"Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds","status":"COMPLETED","sponsor":"Healthpoint","startDate":"2010-09","conditions":"Normal Female Volunteers","enrollment":28},{"nctId":"NCT01359735","phase":"PHASE2","title":"Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients","status":"COMPLETED","sponsor":"Healthpoint","startDate":"2011-05","conditions":"Non-melanoma Skin Cancer","enrollment":8},{"nctId":"NCT00094861","phase":"PHASE2","title":"Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2005-01","conditions":"Dysphagia, Non-Small Cell Lung Cancer, Lung Cancer","enrollment":100},{"nctId":"NCT00852995","phase":"PHASE2","title":"Dose Finding Study of HP802-247 in Venous Leg Ulcers","status":"COMPLETED","sponsor":"Healthpoint","startDate":"2009-02","conditions":"Venous Leg Ulcer, Venous Stasis Ulcers","enrollment":228},{"nctId":"NCT01386151","phase":"PHASE2","title":"A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic Patients","status":"COMPLETED","sponsor":"University Hospital Southampton NHS Foundation Trust","startDate":"2009-08","conditions":"Bronchial Asthma","enrollment":24},{"nctId":"NCT01853384","phase":"PHASE3","title":"Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers","status":"TERMINATED","sponsor":"Healthpoint","startDate":"2013-11","conditions":"Venous Ulcer, Venous Stasis Ulcer, Ulcer","enrollment":252},{"nctId":"NCT00101582","phase":"PHASE3","title":"Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2005-08","conditions":"Mucositis, Solid Tumors, Stomatitis","enrollment":188},{"nctId":"NCT01656889","phase":"PHASE3","title":"Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers","status":"COMPLETED","sponsor":"Healthpoint","startDate":"2012-08","conditions":"Venous Leg Ulcers","enrollment":447},{"nctId":"NCT00031148","phase":"PHASE1, PHASE2","title":"Keratinocyte Growth Factor to Prevent Acute GVHD","status":"COMPLETED","sponsor":"FDA Office of Orphan Products Development","startDate":"2001-09","conditions":"Graft-vs-Host Disease","enrollment":72},{"nctId":"NCT00056875","phase":"PHASE1, PHASE2","title":"Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2002-09","conditions":"Graft Versus Host Disease","enrollment":50},{"nctId":"NCT02313792","phase":"PHASE3","title":"Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2015-01","conditions":"Mucositis","enrollment":88},{"nctId":"NCT00189488","phase":"PHASE2","title":"Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2005-12","conditions":"Graft Versus Host Disease, Hematologic Malignancies","enrollment":155},{"nctId":"NCT00109031","phase":"PHASE3","title":"Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)","status":"COMPLETED","sponsor":"Swedish Orphan Biovitrum","startDate":"2005-01","conditions":"Cancer, Lymphoma, Leukemia","enrollment":47},{"nctId":"NCT00393822","phase":"PHASE2, PHASE3","title":"A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer","status":"COMPLETED","sponsor":"Amgen","startDate":"2005-08","conditions":"Colon Cancer","enrollment":100},{"nctId":"NCT01233921","phase":"NA","title":"Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer","status":"COMPLETED","sponsor":"Martin, Paul","startDate":"2010-09","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission","enrollment":6},{"nctId":"NCT00004132","phase":"PHASE2","title":"Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2000-01","conditions":"Drug/Agent Toxicity by Tissue/Organ, Leukemia, Lymphoma","enrollment":""},{"nctId":"NCT00004061","phase":"PHASE2","title":"Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1999-05","conditions":"Leukemia, Lymphoma, Oral Complications","enrollment":111},{"nctId":"NCT00041665","phase":"PHASE3","title":"Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy","status":"COMPLETED","sponsor":"Amgen","startDate":"","conditions":"Stomatitis","enrollment":""},{"nctId":"NCT00587834","phase":"PHASE3","title":"Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue Regeneration","status":"COMPLETED","sponsor":"Organogenesis","startDate":"2007-10","conditions":"Gingival Recession","enrollment":96},{"nctId":"NCT00038792","phase":"PHASE1, PHASE2","title":"Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2000-10","conditions":"Acute Graft Versus Host Disease","enrollment":7},{"nctId":"NCT01528306","phase":"PHASE2","title":"A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa","status":"WITHDRAWN","sponsor":"Healthpoint","startDate":"2012-03","conditions":"Dystrophic Epidermolysis Bullosa","enrollment":""},{"nctId":"NCT00570999","phase":"PHASE2","title":"Palifermin After Haploidentical PBSCT","status":"WITHDRAWN","sponsor":"European Society for Blood and Marrow Transplantation","startDate":"2008-02","conditions":"Non-Hodgkin's Lymphoma or Hodgkin's Disease, Acute Leukaemia, Myelodysplastic Syndrome","enrollment":""},{"nctId":"NCT01547962","phase":"NA","title":"A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached Gingiva","status":"COMPLETED","sponsor":"Organogenesis","startDate":"2005-09","conditions":"Gingival Recession","enrollment":25},{"nctId":"NCT00540332","phase":"PHASE1, PHASE2","title":"A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy","status":"WITHDRAWN","sponsor":"Swedish Orphan Biovitrum","startDate":"2007-10","conditions":"Head and Neck Cancer","enrollment":""},{"nctId":"NCT00718978","phase":"NA","title":"Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS)","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2003-06","conditions":"Burns, Ulcers, Giant Nevi","enrollment":11},{"nctId":"NCT00610818","phase":"","title":"Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2007-07","conditions":"Skin Rash","enrollment":7}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1013,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Fibroblasts and keratinocytes","genericName":"Fibroblasts and keratinocytes","companyName":"Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus","companyId":"institute-of-biophysics-and-cell-engineering-of-national-academy-of-sciences-of","modality":"Biologic","firstApprovalDate":"","aiSummary":"This is a cellular therapy product consisting of cultured fibroblasts and keratinocytes that promote tissue regeneration and wound healing. Used for Wound healing and tissue regeneration, Burn injuries, Chronic wounds.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}